SLBT Latest Press Releases

-- September 2, 2026 --

SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company Globe Newswire 4:10 PM

-- August 27, 2026 --

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform Globe Newswire 8:00 AM

-- August 11, 2026 --

SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of ?d T Cell Therapy in Glioblastoma Globe Newswire 8:00 AM

-- July 17, 2026 --

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology Globe Newswire 8:00 AM

-- July 10, 2026 --

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma Globe Newswire 8:00 AM

-- June 18, 2026 --

SL Science Holding Limited Reports Full Year 2025 Financial Results Globe Newswire 5:13 PM

-- June 16, 2026 --

Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum Globe Newswire 10:18 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software